We are happy to announce that Scandinavian CRO (SCRO) is now operating under the name of Aurevia, following SCRO’s integration into Aurevia. QAdvis, the Swedish quality assurance and regulatory affairs expert, is now also fully integrated into Aurevia. The Aurevia brand was established in January, when Labquality, Artimed, Clinical Consulting, Kasve, and Prisma CRO merged under the same name.
With SCRO fully integrated into the Aurevia team, we are growing our expertise and services and together offer greater value to our customers in the medtech, biotech and pharmaceutical sectors.
Strengthening CRO services and capabilities
As a result of the merger, Aurevia becomes an even stronger full-service Contract Research Organization (CRO) supporting pharmaceuticals, medical devices, and in vitro diagnostic devices, covering all phases of development.
In addition, Aurevia’s Quality Assurance and Regulatory Affairs (QARA) services provide comprehensive support to navigate complex requirements, while External Quality Assessment Services (EQAS) ensure clinical laboratories meet required quality standards.
-“Our legacy of innovation and expertise will continue, while our expertise and growing capabilities ensure comprehensive, agile service. Built on a strong foundation, we are now a larger, united team across four European countries, serving customers in over 60 countries,” says Juha-Pekka Nuutinen, Aurevia’s CEO.
– “We are a team of highly skilled experts with decades of experience working in clinical research, and we take pride in valuing our people and relationships. Together with our QARA colleagues, we can support our clients throughout their product development lifecycle,” says Ulrika Hammarström, Head of CRO at Aurevia and former CEO and Founder of SCRO.
What does this mean for our clients?
For SCRO clients and stakeholders, the name change will not impact ongoing projects — you will continue working with the same experts you know and trust. All contracts, NDAs, and bank details remain unchanged, while our service offering is now supported by the expanded capabilities of Aurevia’s full-service team. Our commitment to custom, high-quality, and flexible service remains at the core of everything we do.
What is Aurevia?
With SCRO joining, Aurevia strengthens its position as a trusted CRO partner for both medical devices and pharmaceuticals, especially across the Nordics and Europe. Aurevia’s global offering reaches beyond clinical research, as the company’s QARA expertise covers the entire lifecycle of medical devices and in vitro diagnostics from early development to post-marketing activities, and our EQAS offering ensures clinical laboratories meet required quality standards.
To learn more about Aurevia and our expanded offering, visit aurevia.com — and please note our new email addresses: firstname.lastname@aurevia.com.
We look forward to continuing our work together under our new name — Aurevia — with even more expertise, innovation, and flexible solutions to meet your business needs and challenges.
Read the full Aurevia press release – SCRO and QAdvis are now Aurevia
